The AZEK Company Inc. – AZEK

The AZEK Company Inc. (NYSE: AZEK), relating to the proposed merger with James Hardie Industries plc. Under the terms of the agreement, AZEK shareholders will receive $26.45 in cash and 1.0340 ordinary shares of James Hardie per share of AZEK common stock owned.

Beacon Roofing Supply, Inc. – BECN

Beacon Roofing Supply, Inc. (NASDAQ: BECN), relating to the proposed merger with QXO, Inc. Under the terms of the agreement, Beacon shareholders will receive $124.35 per share in cash.

OptiNose, Inc. – OPTN

OptiNose, Inc. (NASDAQ: OPTN), relating to the proposed merger with Paratek Pharmaceuticals. Under the terms of the agreement, OptiNose shareholders will have the right to receive $9.00 in cash per share of stock owned, and one contractual contingent value right.

ProAssurance Corporation – PRA

ProAssurance Corporation (NYSE: PRA), relating to the proposed merger with The Doctors Company. Under the terms of the agreement, ProAssurance stockholders will receive $25.00 per share in cash.

Radius Recycling, Inc. – RDUS

Radius Recycling, Inc. (NASDAQ: RDUS), relating to the proposed merger with Toyota Tsusho America, Inc. Under the terms of the agreement, Toyota Tsusho will acquire all shares of Radius, with Radius shareholders receiving $30.00 per share in cash.

Endo, Inc. – NDOI

Endo, Inc. (OTC: NDOI), relating to the proposed merger with Mallinckrodt plc. Under the terms of the agreement, Endo shareholders will own 49.9% of the combined company on a pro forma basis.

2seventy bio, Inc. – TSVT

2seventy bio, Inc. (NASDAQ: TSVT), relating to the proposed merger with Bristol Myers Squibb. Under the terms of the agreement, Bristol Myers Squibb will acquire 2seventy bio, with 2seventy shareholders receiving $5.00 per share in cash.

Avalon GloboCare Corp. – ALBT

Avalon GloboCare Corp. (NASDAQ: ALBT), relating to the proposed merger with YOOV Group Holding Limited. Under the terms of the agreement, Avalon equity holders are expected to own between approximately 2.5% to 2.2% of the common stock of the combined company.

Checkpoint Therapeutics, Inc. – CKPT

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), relating to the proposed merger with Sun Pharmaceutical Industries Limited. Under the terms of the agreement, Checkpoint stockholders will receive, for each share of common stock they hold, a cash payment of $4.10, and a non-transferable contingent value right entitling the stockholder to receive up to $0.70 in cash.

Redfin Corporation – RDFN

Redfin Corporation (NASDAQ: RDFN), relating to the proposed merger with Rocket Companies. Under the terms of the agreement, Redfin shares will be converted into the right to receive 0.7926 shares of Rocket’s Class A common stock.